Q1: Sales 4% below, EBITDA NOK 10m vs ABGSCe of NOK 4m Lower target range likely EBIT estimates larg...
Order momentum from Q4 continues, up 18% y-o-y, de-risking '25e Stronger margin in both segments, bu...
Q1: +29% org. sales growth, SEK 9m adj. EBITA improvement '25e-'27e adj.
Acceleration across segments - organic momentum improved Another (self-funded) Thebalux-size acquisi...
Redeye retains its positive view of Sdiptech following a stable Q1 report.
Redeye comments on Medivir's Q1 report, during which the main events were the completion of the phas...
Redeye was hoping for a bit more in Q1, despite adverse market conditions related to macroeconomic u...
Nettoomsättningen kom in åt det svagare hållet men resultatet förbättrades, drivet av ökade licensin...
Marknadens oro över hur Trumps handelstullar skulle komma att påverka verksamheten kom på skam.
Orders +7%, sales -1%, adj. EBITA +28% vs. our estimates Key takeaway is the continued order strengt...
Relais announced it will acquire Team Verksted Holding AS from Vy Buss AS, making it the largest ope...
Sales in line with ABGSCe, ARR slightly below Limited, downward consensus estimate revisions Highlig...
Sales +11% y-o-y, in line with ABGSCe 5% adj. EBIT beat, 9% adj.
Adj. EBITA -12% vs cons, but organic growth better Est's down 3-4%, but better growth outlook mainta...
Redeye considers Arise’s Q1 2025 report to be a mixed bag, although largely in line with our estimat...
Redeye provides an initial comment on the Q1 2025 report from Tradedoubler.
Redeye thinks that Momentum Group reported mixed results with both sales and EBITA slightly below ou...
Redeye comments on Formpipe’s Q1 report showing an ACV and EBITDA – CAPEX roughly matching our expec...
Sales SEK 9.5m, EBIT SEK -14m (vs. ABGSCe 9.5m and -20m) No system deliveries in the quarter, as exp...
CEO Rikard Fröberg gives a short introduction of his background and his plans for Hexatronic.
